Cellbxhealth PLC

Results of General Meeting and Board Changes

THIS ANNOUNCEMENT.   THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF CELLBXHEALTH PLC.   15 December 2025   CELLBXHEALTH plc ("the Company") Results of General Meeting and Proposed Board Changes   ·    All Resolutions duly passed by Shareholders at General Meeting ·    Subject to due diligence, four appointments to the Board anticipated in January 2026 ·    Peter Collins transitions from Interim CEO to CEO …

Result of Oversubscribed Placing and Subscription

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, REC…

Update to Admission of Fundraising Shares

the Company and Cavendish may agree, not (being no later than 8.00 a.m. on 16 January 2026). Capitalised terms used but not defined in this announcement have the meanings given to them in the Launch Announcement, unless context provides otherwise. For further information:   CelLBxHealth plc +44 (0) 1483 343434 Peter Collins, Chief Executive Officer  investor@CelLBxHealth.com   Cavendish (NOMAD and Broker) Geoff Nash / Isaac Hooper / Hamza Munshi (Corporate Finance) Sunila de Silva (Corporate Broking) Nigel Birks (Life Science Specialist Sales)   +44 (0) 20 7220 0500…

Launch of Retail Offer

THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF CELLBXHEALTH PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMA…

Proposed Placing and Subscription

THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT (INCLUDING…

CelLBxHealth PLC (AIM:CLBX, formerly ANGLE) plans to raise £6.8 million through a share placing, subscription and separate offer for private shareholders at 1p per share. Also proposes share capital reorganisation splitting each 10p share into a new ordinary share (0.05p) and a deferred share (9.95p).

Posted by Proactive Investors (financial media). No risk warnings present despite significant capital restructuring. Does not mention 68% dilution figure or RetailBook/BookBuild involvement. Zero engagement suggests limited reach. URL: https://www.linkedin.com/posts/proactive-investors_cellbxhealth-plans-68-million-fundraise-activity-7398990897075511296-PAKt

Rebrand announcement: ANGLE plc has changed its name to CelLBxHealth plc. Describes new focus on circulating tumour cell (CTC) solutions for research, drug development and clinical oncology.

Rebrand announcement only - no mention of fundraise, placing, dilution, or financial position. Precedes the £6.8m fundraise announcement by 2 weeks. URL: https://www.linkedin.com/posts/angle-technology_we-are-excited-to-announce-that-angleplc-activity-7394007190396903424-E5l1